---
title: "Exploring drug repurposing approaches for Parkinson's disease"
title-slide-attributes:
  data-background-image: img/roberto-sorin-RS0-h_pyByk-unsplash.jpg
  data-background-size: contain
  data-background-opacity: "0.5"
author: "Julia Romanowska, Trond Riise"
format:
  revealjs:
    date-format: "YYYY-MM-DD"
    theme: moon
    logo: "img/UiBmerke_grayscaleV8_white_transp.png"
    template-partials:
      - title-slide.html
date: '2024-02-19'
---

```{r}
#| include: false
#| label: setup
library(fontawesome)
```

## DRONE

<img src="img/DRONE-webpage.png" style="height: 100%; position: absolute; top: 2px; right: 2px;">

## DRONE and TRACE

```{=html}
<img src="img/SFF_Forenklet_no_bck.png" style="width: 50%;">
<img src="img/DRONE-webpage.png" style="height: 100%; position: absolute; top: 2px; right: 2px;">
```

## DRONE and TRACE

`r fa("people-group")` **Epidemiology:**    
registry-based research

:::notes
- we're checking the Prescription Registry
:::

. . .

`r fa("robot")` **Bioinformatics:**    
molecular databases, enrichment in GWAS

:::notes
- 
:::

. . .

`r fa("file-prescription")` **Medical statistics:**    
new methods, time-dependent exposure, emulated target trials

:::notes
- new methods: _agnostic search for associations_
:::

. . .

`r fa("flask-vial")` **Experimental systems:**    
collaboration with Harvard and Yale

:::notes
- collaboration with Boston
:::

## DRONE - who we are?

#### Locally `r fa("arrow-right")`

```{=html}
<img src="img/drone_group_photo_2022.jpg" style="position:absolute; right: 2px; top: 10px; width: 60%;">
```

+ NeuroSysMed    
![](img/Neuro-SysMed_RGB_Logo.png)

<br>

#### Internationally:

- Marianna Cortese, Harvard
- Kjetil Bj√∏rnevik, Harvard
- Clemens Scherzer, Yale

## DRONE - what we do?

```{=html}
<img src="img/workflow_project_analyses_vertical.png" style="width: 80%">
```

:::notes
DRONE = drug repurposing for neurological diseases;

drug repurposing = we have entire Prescription registry to look into;
more than 600 million prescriptions, ca.4.5 million Norwegians, 2004--2019
:::

:::alert
**MAIN AIM:** find drugs that influence risk of disease
:::

:::notes
influence = reduce or increase;

drugs that increase risk can give information about disease genesis;

drugs that decrease risk can be potentially used as new treatment options
:::

## DRONE - Research projects

**Parkinson's disease (PD)** - Julia Tuominen, Asieh Moufrad _(until April)_, Muhammad Eid _(graduated)_

**Multiple sclerosis (MS)** - Akash Kapali

**Amyotrophic lateral sclerosis (ALS)** - Magne Solheim

## DRONE - Communication

```{=html}
<div>
<img src="img/JuliaT_article.png" style="width: 32%;">
<img src="img/JuliaR_article.png" style="width: 32%;">
<img src="img/Akash_article.png" style="width: 32%;">
</div>
```

- `r fa("person-chalkboard")` 19 presentations on conferences and seminars
- `r fa("people-line")` 5 gatherings
- `r fa("newspaper")` 3 media articles
- `r fa("graduation-cap")` 1 Master thesis defended
- `r fa("laptop-code")` thousands of lines of code

:::notes
list of papers + posters + presentations; photos of Julia T and Akash presenting
:::

## New project

```{=html}
<img src="img/mjfox_logo.png" style="position: absolute; right: 2px; top: 2px; width: 600px;">
```
. . .

<br>

_Finland:_ **Anna-Maija Tolppanen**    
School of Pharmacy, Faculty of Health Sciences, Univ.of Eastern Finland

<br>

_France:_ **Alexis Elbaz**    
French Institute of Health and Medical Research, Inserm

:::notes
they both have 
:::

## New project - Idea

Cross-validation of findings from: _Norway, France, and Finland_

1. Cross-validate methodology _(Finland)_

2. Meta-analysis _(Norway)_

3. Cross-validate significant findings _(all)_

